Skip to main content
رجوع
Watch Compare

Picard Medical, Inc.

جودة البيانات: 100%
PMI
NYSE Manufacturing Measuring & Analyzing Instruments
KWD 1.01
▼ KWD 0.01 (-0.98%)
القيمة السوقية: 75.93 M
السعر
KWD 1.01
القيمة السوقية
75.93 M
نطاق اليوم
KWD 1.00 — KWD 1.05
نطاق 52 أسبوعًا
KWD 0.92 — KWD 13.68
حجم التداول
35,218
فتح KWD 1.03
متوسط 50 يوم / 200 يوم
KWD 1.34
24.34% below
متوسط 50 يوم / 200 يوم
KWD 3.65
72.33% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -15.67 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-546.60%
Op. Margin-268.36%

الأمان

Debt / Equity
N/A
Current Ratio2.16
Interest CoverageN/A

التقييم

PE (TTM)
-2.81
أقل من متوسط القطاع (-1.98)
P/B Ratio9.53
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -2.8 -2.0
P/B 9.5 5.1
ROE % — -51.0
Net Margin % -546.6 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.94 M Net Income (TTM) -27.00 M
ROE N/A ROA -214.10%
Gross Margin -4.13% Operating Margin -268.36%
Net Margin -546.60% Free Cash Flow (TTM) -15.67 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2.16
Interest Coverage N/A Asset Turnover 0.39
Working Capital 6.22 M Tangible Book Value 6.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.81 Forward P/E N/A
P/B Ratio 9.53 P/S Ratio 15.37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -20.64%
Market Cap 75.93 M Enterprise Value 73.12 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.07
FCF / Share -0.21 OCF / Share -0.21
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 58.04%
SBC-Adj. FCF -16.43 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 4.94 M
Net Income -27.00 M
EPS (Diluted) —
Gross Profit -204,000.0
Operating Income -13.26 M
EBITDA —
R&D Expenses 3.05 M
SG&A Expenses 10.00 M
D&A 163,000.0
Interest Expense —
Income Tax 35,000.0

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 22.55 M
Total Liabilities 18.76 M
Shareholders' Equity 3.79 M
Total Debt —
Cash & Equivalents 7.45 M
Current Assets 20.73 M
Current Liabilities 18.70 M